Market Research Blog

The cleanroom technologies market study conducted by Future Market Insights is projected to expand at a CAGR of 6% to US$ 13.29 Bn by 2032, up from US$ 7 Bn in 2021. The rising demands for sterilized pharmaceutical formulations and the growing demand for medical device cleanrooms are driving this cleanroom technologies market growth.

In the subsequent years, technological advancements in cleanroom technology and rising demand for cleanroom technologies in developing economies are likely to provide significant cleanroom technologies market potential possibilities.

The study finds that cleanroom technologies market constraints associated with their operational expenses and the technical problems associated with modifying cleanroom designs in developing economies are hampering the cleanroom technologies market growth.

ISO 6 cleanrooms and ISO 8 cleanrooms have different prices per square foot. This is due to the fact that the volume of air delivered in both types of cleanrooms differs. In an ISO 6 cleanroom, the air is 100 times cleaner than in an ISO 8 cleanroom, increasing the air conditioning capacity of the HVAC systems.

The demand to maintain an antimicrobial environment by eliminating airborne particles in these facilities increases as the number of hospitals and Ambulatory Surgery Centers (ASCs) grows due to the various perks they provide.

There are no defined cleanroom design standards for various application areas or product types. This presents several difficulties for cleanroom technologies manufacturers, as they must adhere to various designs each time. There are no requirements for environmental, product, or facility factors to be controlled in the legislation. Instead, they only give requirements that a corporation must follow after manufacturing a product in a cleanroom setting.

Consumables dominated the cleanroom technology market in 2020, accounting for the most revenue. Another critical factor attributing to the segment’s highest cleanroom technology market share is the frequent usage of consumables and high sales of cleanroom consumables, notably gloves.

Due to the particular sensitivity of processes, cleanroom technology is vital for biotechnology-based operations such as research and development, biocontamination control, pilot studies, and production facilities. Consequently, demand for cleanroom technology is anticipated to grow as the biotechnology industry grows significantly over the forecast period.

According to the report, North America dominated the cleanroom technology market, accounting for most sales of cleanroom technology.

This is due to the region’s well-established healthcare infrastructure, the presence of significant pharmaceutical and medical device cleanroom businesses on the ground, an increase in the burden of non-communicable diseases, and growth in cosmeceutical and nutraceutical awareness. Moreover, restrictive laws governing the approval of healthcare items in this region, such as the United States, have boosted demand for cleanroom technology.

Get Sample PDF Brochure: 

https://www.futuremarketinsights.com/reports/sample/rep-gb-14283

Key Takeaways:

• The consumables segment leads the cleanroom technology market in 2020, accounting for 54.1% of total revenue.
• In 2020, the pharmaceutical industry segment was expected to dominate the cleanroom technology market by end-use, accounting for 40.3% of total revenue.
• Due to the increased acceptance of biotechnology commodities worldwide, the biotechnology industry segment in the cleanroom technologies market is predicted to develop at the fastest rate of 7.2% over the forecast period.
• The equipment segment held a dominant position in the cleanroom technologies market in 2019, accounting for 74.2% share in terms of value.
• North America held the largest cleanroom technology market share in 2020, accounting for 35.5% of total revenue.

Competitive Landscape:

The cleanroom technology market is highly fragmented, with more regional competitors than cleanroom technology market manufacturers present. Mergers and acquisitions, as well as R&D relating to modular cleanroom systems’ developments, are some of the major strategies used by leading firms to grow their cleanroom technology market share.

The major cleanroom technology market manufacturers covered in the cleanroom technology market report are Simplex Isolation Systems, AES Clean Technology, DuPont, Clean Air Products, Clean Room Depot, Inc., Integrated Cleanroom Technologies Private Limited, Hemair, AIRTECH JAPAN, Ltd., Lennox International Inc., COLANDIS GMBH, ABN Cleanroom Technology, Nicos Group, Inc., Galvani S.r.l., ANSELL LTD., Ardmac, Azbil Corporation, novum. Reinraumtechnik, Helapet Ltd., KCWW, Camfil, Labconco, Taikisha Ltd, Terra Universal. Inc. and Lindner Group, among other domestic and universal cleanroom technologies market manufacturers.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-14283

Key Segments

By Product Type:

• Equipment
• Fan Filter Unit (FFU)
• HVAC Systems
• Laminar Air Flow Systems and Biosafety Cabinets
• HEPA Filters
• Air Diffusers and Showers
• Safety Consumables
• Cleaning Consumables

By End User:

• Pharmaceuticals Industry
• Biotechnology Industry
• Medical Device Manufacturer
• Hospitals

By Construction Type:

• Standard/Drywall Cleanroom
• Hardwall Cleanroom
• Softwall Cleanrooms
• Terminal Boxes

By Region:

• North America
• Latin America
• Europe
• Asia-Pacific
• Middle East & Africa

Inquire Before Buying This Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-14283

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

According to a recent lateral flow assays market report by Future Market Insights (FMI), the lateral flow assays market was valued at US$ 11 Bn in 2021, is projected to reach US$ 12.5 Bn by 2026, and is anticipated to grow at a CAGR of around 2% over the projected period of 2022-2032.

The high rate of infectious diseases around the world, explosive growth in the geriatric population, escalating demand for point-of-care testing, and increased use of home-based rapid lateral flow devices are all boosting lateral flow assays market forward. The significant restraints are doctors’ and patients’ reluctance to change existing diagnostic techniques and the low accuracy of lateral flow assays.

The affordable cost of lateral flow assays devices and the fact that no trained personnel is required to run the tests are two factors driving up demand for lateral flow assays-based devices for COVID-19 testing. The growing adoption of kits & reagents due to innovations and benefits of lateral flow assays rapid tests over laboratory tests the high number of lateral flow assay rapid detection kits launched by healthcare companies, predominantly for lateral flow assay COVID-19 testing, are all factors contributing to the large share of the kits & reagents segment. Sandwich assays have a considerable part of the lateral flow assays market due to the growing use of sandwich assays in medical testing and the benefits of sandwich assays.

Despite the fact that lateral flow assay tests are simple to implement and less affordable than laboratory testing, they are less reliable. Due to the apparently limited accuracy of the lateral flow assay kit, most doctors and patients prefer molecular studies to fast tests for more accurate COVID-19 diagnosis. As a result, major diagnostic lateral flow assays market participants are concentrating their efforts on developing more laboratory-based infectious disease testing solutions.

Infectious disease lateral flow assays diagnostics, cardiac disease diagnosis, and veterinary applications are typical applications for lateral flow tests. However, the use of lateral flow technology has grown in various new applications in recent years. Potential applications for lateral flow tests include saliva diagnostics, behavioural health, agriculture (crop quality testing), biowarfare (anthrax detection), environmental testing, and food microbiology. Lateral flow assay (immunochromatography tests/lateral flow immunoassays) technologies continue to dominate the point of care diagnostic market through 2024. The acquisition and validation of vital reagents are one of the most challenging elements of producing lateral flow assay tests. Antibodies used in assays must be evaluated for accuracy, specificity, stability, and reproducibility, as any reagent flaws can cause the lateral flow assay to fail. Another obstacle is lateral flow assays diagnostics after an antibody or antibody pair has been found.

Key Takeaways

• The Kits & Reagents segment is anticipated to grow at a rapid CAGR of 5.3% during the forecast period.
• The clinical testing segment accounted for 90.9% of the lateral flow tests market.
• With a lateral flow tests market share of 70.9% in 2020, sandwich assays dominated the lateral flow tests market.
• Blood samples were the most preferred, with a 53.1% lateral flow tests market share.
• The hospitals and clinics segment was the most favoured, with a lateral flow tests market share of 37.6%.
• China, the world’s second-largest economy, is expected to reach a lateral flow tests market size of US$917 million in 2027, with an annual growth rate of 8.8%.
• Within Europe, Germany is expected to show a lateral flow tests market growth at a 4.8% compound annual growth rate (CAGR), while the rest of the European market will reach US$917 million by 2027.
• The Asia Pacific region is expected to increase at a CAGR of 4.2% during the forecast period.

Get Sample PDF Brochure: 

https://www.futuremarketinsights.com/reports/sample/rep-gb-14271

Competitive Landscape

Some companies have increased their lateral flow tests market share through various strategies such as mergers and acquisitions. In contrast, others invent new diagnostic market test methods and provide innovative goods to maintain their market share.

Key Segments

By Application:

• Clinical Testing
• Veterinary Diagnostics
• Food Safety & Environmental Testing
• Drug Development & Quality Testing

By Technique:

• Sandwich Assays
• Competitive Assays
• Multiplex Detection Assays

By Sample Type:

• Blood Samples
• Urine Samples
• Saliva Samples
• Others
• By Type
• Kits & Reagents
• Lateral Flow Readers

By End User:

• Hospitals & Clinics
• Diagnostics Laboratories
• Home Care Settings
• Pharmaceuticals & Biotechnology Companies
• Others

By Region:

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East and Africa

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-14271

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Summary of Statistics

1.3. Key Market Characteristics & Attributes

1.4. Fact.MR Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment

3.1. Risk Assessment

3.1.1. COVID-19 Crisis and Impact on Lateral Flow Assays Demand

3.1.2. COVID-19 Impact Benchmark with Previous Crisis

3.1.3. Impact on Market Value (US$ Mn)

3.1.4. Assessment by Key Countries

3.1.5. Assessment by Key Market Segments

3.1.6. Action Points and Recommendation for Suppliers

3.2. Key Trends Impacting the Market

3.3. Formulation and Product Development Trends

Inquire Before Buying This Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-14271

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

The global demand for drug discovery services market is expected to rise at a 14.5% CAGR to acquire a valuation of US$ 50.9 Bn by the end of forecast period 2022-232. The global drug discovery services market size was valued at US$ 15.5 Bn in 2021 and is projected to reach a valuation of US$ 32 Bn by 2026

The global drug research services industry is booming as a result of increased funding for research and innovation in a multitude of segments. The drug discovery process is a significant part of the pharmaceutical sector. The study on drug discovery services market finds that the efforts of researchers towards the development of new drug prototypes have popularized outsourcing of drug discovery services. Moreover, growing spending on research and the development of novel medications for the treatment of deadly diseases and disorders has stimulated the demand for drug discovery platform. Pharmaceutical and biopharmaceutical businesses are opting for seamlessly engaged and multifunctional solution providers for drug discovery research, from the developing phase to the late testing stages. Emerging trends in drug discovery services market portends that pharmaceutical companies opt for outsourcing as a key choice to offset the shortage of in-house manpower required for new product development, as pharmaceutical businesses face great pressure to reduce overhead costs.

Restrictive laws regulating drug research and animal testing are projected to limit drug distribution to some extent. Drug discovery service organizations are facing restrictions due to a limitation of trained employees. The use of animals in pharmaceutical research is governed by strict laws. Mice, rats, fish, amphibians, and reptiles are the most common animals utilized in scientific studies. Considerations over the ethical use of animal experimentation have prompted countries to enact animal safety and use statutes, which raises a number of impediments to the future of drug discovery services market.

The drug discovery trends indicate that Biologics, such as proteins, peptides, and monoclonal antibodies, account for more than half of the therapeutic possibilities in the initial cycle. In 2022, biologics are estimated to make up for approximately half of the income earned by the top 100 pharmaceutical drugs. As per the global market study on drug discovery services, they provide the drug discovery services market with highest growth potential through the forecast period.

Despite the fact that small-molecule pharmaceutical companies monopolize the global pharmaceutical market, players working with biologics, biosimilars, and large-molecule drugs are tapping into the drug discovery services market opportunities primarily to introduce new biologic-based treatments and rising revenue from current biologics.

All-in-all, the drug discovery services market is expected to reach a valuation of US$ 32 Bn by 2026.

Get Sample PDF Brochure: 

https://www.futuremarketinsights.com/reports/sample/rep-gb-14258

Key Takeaways

• The drug discovery services market is divided into two types–chemistry and biology services. In 2020, the chemistry drug discovery services category held the greatest proportion of the market.
• Small molecules are expected to occupy the largest share of revenue when compared to biologics. Drug discovery statistics specify that small molecules are expected to generate more than US$ 10,800 million in revenue by the end of 2026.
• The oncology category is predicted to have the leading position, owing to the increasing number of cancer patients around the world.
• In comparison to other innovative drug discovery services, Hit-To-Lead identification is expected to acquire the most traction.
• As the most revenue generating phase, several CROs are already delivering Hit-to-lead identification services to pharmaceutical corporations.

“The Asia Pacific drug discovery services market growth is anticipated to be the highest during the projected duration, owing to expansions happening in the pharmaceutical and biopharmaceutical industry. A high proportion of contract research organizations (CROs), government incentives, high research and development in pharmaceutical industry, and the involvement of less restrictive standards for drug discovery programs (particularly in terms of using animals for research) across several APAC countries are some drivers sustaining the healthy growth of the drug discovery services market.”, opines a seasoned FMI analyst.

Competitive Landscape

The COVID-19 pandemic highlighted the importance of outsourcing drug discovery services for companies and research groups in North America. These companies are now working together with the government to facilitate the drug discovery process.

• Existencia, a business using artificial intelligence in drug discovery, announced a collaboration with Diamond Light Source and Scripps Research on March 31, 2020, to identify COVID-19 antiviral treatments.
• Samsung Biologics, a South Korean pharmaceutical business, has signed a long-term partnership with Eli Lilly and Company to develop bamlanivimab, an investigational COVID-19 virus-neutralizing antibody.

Genesis Therapeutics and Genentech announced a multi-target drug discovery AI partnership in November 2020. Genesis’ graph machine learning and drug discovery skills will be used in this cooperation to identify novel drug candidates for therapeutic targets in a variety of illness domains.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-14258

Key Segment

By Process:

• Target Selection
• Target Validation
• Hit-to-Lead Identification
• Lead Optimization
• Candidate Validation

By Type:

• Chemistry Services
• Biology Services

By Drug Type:

• Small Molecules Drugs
• Biologics Drugs

By Therapeutic Area:

• Neurology
• Infectious and Immune System Diseases
• Digestive System Diseases
• Oncology
• Other Therapeutic Area

By End User:

• Pharmaceutical & Biotechnology Companies
• Academic Institutes
• Manufacturing
• Other End Users

By Region:

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East and Africa

Inquire Before Buying This Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-14258

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

According to a recent study by Future Market Insights (FMI), the cold disposable biopsy forceps market is expected to witness high growth during the forecast period. The market value is slated to increase from US$ 505.1 Mn in 2020 to over US$ 1.2 Bn by 2031 at 8.4% CAGR over the forecast period (2021-2031).

The cold disposable biopsy forceps market will register high demand due the rising prevalence bronchitis and gastrointestinal disorders such as IBD and GERD among the geriatric population and the increasing awareness towards endoscopic procedures. There is also a rise in the adoption of disposable biopsy forceps that to be reliable for test sampling expects to gain popularity.

At present, the minimally-invasive technology, with the endoscope system at the core, has been extended to obstetrics, general surgery, otolaryngology, gynecology, thoracic surgery, urology, pediatrics, and other departments. Minimally-invasive endoscopic technology has become an indispensable technology for the diagnosis and treatment of chronic diseases associated with breathing, digestion, urology, otolaryngology, and so on.

With the rising demand for endoscopic minimally-invasive technology and continuous improvement in endoscopic processing technology, endoscopic applications have become prominent in almost all departments. The growing demand for diagnosis and endoscopic treatment is expected to further boost the demand for cold disposable biopsy forceps.

Numerous recent technological advances are becoming available to endoscopists. An abundance of new imaging modalities is expected to facilitate early detection of chronic disorders and other pathological entities. Most of these techniques remain investigational and are currently in clinical trials to determine patient benefits.

Companies are expanding their product lines by manufacturing different types of products for a wide range of applications.

For instance, Micro-Tech Endoscopy is mainly engaged in the R&D, manufacturing, and sales of minimally-invasive medical devices, in line with its mission of supporting clinicians with technology and innovation.

Key Takeaways from Cold Disposable Biopsy Forceps Market Study

• Oval cup forceps gained popularity and their sales are expected to grow at a CAGR of 8.8% during the forecast period.

• 2.8 mm diameter have sharpened cups whch ensure superior cutting performance and lead to fewer artefacts and less bleeding. The segment is therefore expected to account for a share of 24.9% in 2021.
• 2300 mm length forceps has precise jaws, no tearing and cause small wound. The segment accounted for the highest share of 37.9% in 2021.
• Upper GI Endoscopy dominated the application segment with the highest market share of 24.9% in 2021.
• Hospitals accounted for the largest share of around 42.0% in 2021 and will remain the end user in the market.

“High prevalence of conditions such as IBD and GERD and growing demand for minimally invasive endoscopic procedures are set to boost the demand for cold disposable biopsy forceps market over the next decade,” says the Future Market Insights analyst.

Get Sample PDF Brochure: 

https://www.futuremarketinsights.com/reports/sample/rep-gb-14240

Who is winning?

The key players are focusing on acquisitions and partnerships with small players and suppliers to increase their market presence. Besides this, they are adopting various strategies to expand their footprint. For instance:

iIn April 2018, Boston Scientific Corporation closed its acquisition of NxThera. The company developed a minimally-invasive therapy the Rezūm system, for patients suffering from symptomatic benign prostatic hyperplasia. With the completion of the acquisition, NxThera became a part of Boston Scientific’s urology and pelvic health business. Moreover, the manufacturers are focusing on research and development activities for developing cold disposable biopsy forceps for various research applications.

In july 2020, ChargePoint and STERIS collaborated to develop a fully validated sterile transfer solution to offer a unique and integrated solution for sterile product transfer.

Some of the leading players in the cold disposable biopsy forceps market include but are not limited to Olympus Corporation, Boston Scientific Corporation, STERIS, CONMED Corporation, Cook Medical, Micro-Tech Endoscopy, Anrei Medical and other companies.

Key Market Segments Covered in Cold Disposable Biopsy Forceps Industry Research

By Product:

• Oval Cup
• Oval Cup with Needle
• Alligator Jaw
• Alligator Jaw with Needle

By Diameter Size:

• 1.2mm
• 1.8mm
• 2.0mm
• 2.4mm
• 2.8mm
• 3.7mm

By Length:

• 1150mm
• 1550mm
• 2300mm

By Application:

• Enteroscopy
• Upper GI Endoscopy
• Lower GI Endoscopy
• Bronchoscopy
• Others

By End User:

• Enteroscopy
• Upper GI Endoscopy
• Lower GI Endoscopy
• Bronchoscopy
• Others

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East & Africa (MEA)

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-14240

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusion and Exclusions

3. Market Background

3.1. Macro-Economic Factors

3.1.1. Global GDP Growth Outlook

3.1.2. Global Healthcare Expenditure Outlook

3.1.3. Emerging Countries Healthcare and Development Outlook

3.2. Forecast Factors – Relevance & Impact

3.2.1. Adoption of Device Product

3.2.2. Rising Prevalence of Tumours

3.2.3. Historical growth of key players

3.2.4. New product launches and approvals

3.2.5. COVID-19 Impact

3.2.6.  Reimbursement scenario

3.2.7. Expansion by Leading Manufacturer in Emerging Geographies

3.3. Market Dynamics

3.3.1. Drivers

3.3.2. Restraints

3.3.3. Opportunity Analysis

Inquire Before Buying This Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-14240

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

According to a recent Future Market Insights (FMI) industry analysis, the demand in the high-end cellomics market is expected to top US$ 288.8 Mn in 2021, growing at a CAGR of 6.4% during the forecast period 2021-2031.

High-end cellomics is a process that is utilized in drug discovery and biological research to identify substances such as small molecules, RNAi or peptides which alter the phenotype of a cell in a wanted manner.

The global high-end cellomics market is primarily driven by increasing technological advancement in imaging solutions. Technological advancements such as the usage of polarization methods, multicolored fluorescence-based reagents, automated imaging technology, and flow cytometry are also anticipated to boost the market growth further.

Increasing investment in research and development in cellular science of novel molecules by private and government organizations, technological advancement in imaging solutions, and advantages related to these innovations such as improved scope for pplication in gene documentation & neonatal development learning will drive the high-end cellomics market.

Key Takeaways from High-end Cellomics Market Study

• The global high-end cellomics market is expected to reach US$ 536.9 Mn by 2031.
• By application, drug discovery accounted for 55.5% of overall sales in 2021 and is expected to continue to grow at the same trend during the forecast period.
• By end-users, pharmaceutical and biotechnology companies will account for the largest share of 51.8% during the forecast period.
• By region, North America held the largest share of 32.7% of the global high-end cellomics market.
• By country, the U.S. is the most lucrative market in the global high-end cellomics market with US$ 81.7 Mn revenue in 2021.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-14164

Who is Winning?

Some of the leading manufacturers of high-end cellomics are focusing on product approvals and launch strategies for global expansion objectives, thereby, enhancing their market presence. The leading key players are focusing on strategic alliance to expand the product offerings.

Yokogawa Electronic Corporation in December 2020, agreed with InSphero AG to jointly promote the use of Yokogawa’s high-end cellomics systems for drug discovery research which actively involves the use of 3D in vitro models.

The key market players covered by FMI include PerkinElmer, Inc., ThermoFisher Scientific, Inc., Molecular Devices LLC (part of Danaher Corporation) and Yokogawa Electric Corporation.

About the Healthcare Division at Future Market Insights

Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business. Know more about our sector coverage here

High-end Cellomics Market by Category

Application:

• Academic Research/Basic Research
• Drug Discovery
  • Primary & Secondary Screening
  • Target Identification & Validation
  • Invitro Toxicity Studies
  • Compound Profiling

End-User:

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Independent Contract Research Organizations (CROs)

Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• The Middle East and Africa (MEA)

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-14164

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusion & Exclusion

3. Key Trends

3.1. Key Trends Impacting the Market

3.2. Trends in Diverse Application

4. Key Success Factors

4.1. Key Products USP Analysis

4.2. Key Manufacturers Promotional Strategies

4.3. Value Chain Analysis

4.4. PESTLE Analysis

4.5. PORTERS Analysis

4.6. Key Regulations

Inquire Before Buying Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-14164

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

The global needle-free injectors market is likely to accumulate value of US$ 13.78 Billion in 2022, and is expected to reach US$ 42.79 Billion by registering a CAGR of 12% in the forecast period 2022-2032.

Needle-free injection is an innovative drug delivery technology that drives drugs to the skin using force which virtually nullifies the use of hypodermic needle. With growing preference for non-invasive drug delivery system and vaccines, adoption of needle-free injectors is expected to improve over the coming years

Application of needle-free injectors is increasing with rising incidence of diabetes and other chronic diseases across the globe. With increasing number of surgeries, demand for minimally invasive procedures is accelerating the sales of needle-free injectors.

According to Centers for Disease Control and Prevention (CDC), more than 51% of adults in U.S. had at least 1 chronic condition, and 27.2% had multiple chronic conditions in 2018.

Other factors driving the global demand are cost-effectiveness and safety related to needle-free injectors.

Request Sample Report:

https://www.futuremarketinsights.com/reports/sample/rep-gb-13960

Key Takeaways from Needle-free Injectors Market study

• By load type, liquid injections segment will hold around 88.0% of value share globally.
• Based on the technology, spring-loaded jet injector is dominating the market, with over 48.0% of the market share.
• Based on the delivery site, intra dermal injector is expected to hold over 33% of the market share.
• Application of drug delivery will spur the sales of needle-free injectors, with the segment accounting for 65% of the market share.
• Based on the usage, reusable needle free injectors are highly sought-after, contributing over 78% of the market revenue.
• Hospitals are expected to be the primary end-users, holding a market share of 28% during the forecast period.
• By region, North America will dominate the global needle-free injectors market, holding 42% of total market share.
• Europe is expected to be the second-largest market, with Germany spearheading the market growth .
• India will emerge as the most lucrative market across South Asia, accounting for nearly 50% of market share in 2021.
• China will hold leading position in East Asia and is expected to account for nearly 46% of market share.

“Growing prevalence of chronic diseases coupled with rising preference of non-invasive drug delivery system will improve the adoption of needle-free injectors. With rising demand for needle-free injectors, key players are introducing new product launches and are aiming for fast track approvals to capitalize on existing opportunities and sustain their position in the industry “says the FMI Analyst.

Who is Winning?

New product launches and approvals, agreements, and collaborations are some of the key growth strategy adopted by the key players. By focusing on these strategies, key players intend to expand their global presence and strengthen their existing product portfolio.

For instance,

• In November 2019, Antares Pharma collaborated with Idorsia for the development of a novel self-administered drug-device product.
• In June 2020, Vitaeris Inc., a biotech company was acquired by CSL Limited. The acquisition was carried out by CSL Limited to achieve the motive of addressing the unmet needs of patients.

The key market players covered by FMI include Pfizer, Inc., Gerresheimer AG, Ferring Pharmaceuticals, CSL Limited (Seqirus UK Limited) and others.

Browse Full Report:

https://www.futuremarketinsights.com/reports/needle-free-injectors-market

Key Segments Profiled In The Needle-Free Injectors Market Industry Survey

Needle-Free Injectors Market by Load:

• Needle-Free Injectors by Liquid Injections
• Needle-Free Injectors by Powder Injections
• Needle-Free Injectors by Projectile Injections

Needle-Free Injectors Market by Technology:

• Needle-Free Injectors by Spring-loaded jet injector
• Needle-Free Injectors by Battery-powered jet injector
• Needle-Free Injectors by Gas-powered jet injector

Needle-Free Injectors Market by Delivery Site:

• Needle-Free Injectors by Intra dermal injectors
• Needle-Free Injectors by Intramuscular injectors
• Needle-Free Injectors by Subcutaneous injectors

Needle-Free Injectors Market by Application:

• Needle-Free Injectors by Drug Delivery
• Needle-Free Injectors by Vaccines
• Needle-Free Injectors by Cosmetic
• Needle-Free Injectors by Others

Needle-Free Injectors Market by End User:

• Needle-Free Injectors by Home Care Settings
• Needle-Free Injectors by Long Term Care Centers

Needle-Free Injectors Market by Region:

• North America Needle-Free Injectors Market
• Latin America Needle-Free Injectors Market
• Europe Needle-Free Injectors Market
• East Asia Needle-Free Injectors Market
• South Asia Needle-Free Injectors Market
• Oceania Needle-Free Injectors Market
• Middle East & Africa Needle-Free Injectors Market

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-13960

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

According to a recent study by Future Market Insights (FMI), the global Bioprocess Technology Market was valued at US$ 17.3 Bn in 2020 and is expected to register a CAGR of 15.2% during the forecast period (2021-2031). It is projected to generate a revenue of US$ 81.2 Bn by the end of 2031.

Technology has always been at the heart of biotech. The emergence of advanced computing technology such as machine learning and artificial intelligence has enabled companies to expand the scale of their research and improve efficiency in the manufacturing process—both of which reduce the time it takes for biotech firms to bring new products to market.

Increasing research and development spending on pharmaceutical products has improved the well-being of patients to a significant level. Today vaccines have proven to be one of the most effective ways to prevent children from infectious diseases. This is highly possible due to increased government spending on research & development in the life science stream.

For instance, in May 2020, AbSci Inc. closed USD 15.4 Mn in series D funding to accelerate the growth and scale of disruptive protein printing technology, by announcing an exclusive co-marketing partnership with KBI Biopharma.

There are currently more than 1,500 biomolecules undergoing clinical trials, which target more than 100 hundred types of diseases and success rate for biologics has so far been over twice that of small-molecule products.

Key Takeaways from Bioprocess Technology Market Study

• In 2021, the BIOTECH/BIOPHARMACEUTICAL COMPANIES segment is expected to dominate the global bioprocess technology market with a 44.0% market share, whereas, CDMO/contract research organization segment is expected to occupy over 40% of the market share.
• By product, the upstream segment dominated the global Bioprocess Technology Market with a 64.8% market share.
• Europe and East Asia dominated the global Bioprocess Technology Market occupying over 24.3% and 14.7% market share, respectively.

Who is winning?

Some of the leading companies of Bioprocess Technology Market are focusing on their extensive portfolio of single-use cell culture bioreactors, containers, strong distribution channels, and strategic selling to the leading biopharmaceutical manufacturing entities.

• Thermo Fisher Scientific Inc. is a multinational biotech company that develops, manufactures, and distributes products in the areas of healthcare & diagnostics, life sciences, pharmaceuticals, and others. In Sep 2020, Thermo Fisher Scientific Inc. announced the opening of its new Bioprocessing Collaboration Center (BCC) in St. Louis, Missouri.
• Sartorius AG is a leading provider of contract testing services to the global biotechnology and biopharmaceutical industries. In July 2020, Sartorius Stedim Biotech acquired a majority stake in CellGenix to strengthen its product portfolio for cell and gene therapies.
• Danaher Corporation designs manufacture and markets professional, medical, industrial, and commercial products and services. In March 2020 Danaher Corporation acquired the Biopharma business from General Electric’s Life Sciences division.

The key market players covered by FMI include Thermo Fisher Scientific Inc, Sartorius, Merck KGa, Danaher Corporation, Applikon Biotechnology B.V., Lonza AG, Bio-Rad Laboratories, Agilent technologies, Solida Biotech GmBH, and Waters Corporation.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-13890

Key Segments:

Product:

• Upstream Equipment
  • Cell culture development products
    • Cell line development products
    • Cell Lines
    • Media, Sera and other additives
    • Cell line development kits
• Lab-scale Bioreactors
  • Continuous Stirred Tank Bioreactors
  • Bubble Column Bioreactors
  • Airlift Bioreactors
  • Fluidized Bed Bioreactors
  • Packed Bed Bioreactors
  • Photo-Bioreactors
• Scale-up and production products
  • Cell culture media and feeds
  • BioProcess Containers & Fluid Transfer Solutions

1. Single-use
2. Reusable

• • BioReactors

1. Single-Use Bioprocess Equipment
2. Continuous Bioprocess Equipment
3. Real-Time Bioprocess Equipment

• • Harvest and collection

• • • Harvest and separation products
    • Centrifuges for bioprocessing
    • Storage & Transport Products
      v. Production Tanks and Drums
      v. Outer Support Containers
• Testing Products
  • Cell Counters & Viability Analysis Systems
  • Contamination & impurity testing products
• Probes and Accessories
• Downstream Equipment
  • Downstream purification
    • Chromatography Instruments
    • Chromatography Columns
    • Others (Resins and accessories)
  • Buffer preparation and supply
    • Reagents
    • mixing systems
• Process analytical testing
  • Host cell residual DNA quantitation
  • Protein quantitation
  • Microbial identification
  • Others
• Probes and Accessories

End-User:

• Biotech / Biopharmaceutical Companies
• CDMO / Contract Research Organization
• Research / Academic Institutes

Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• The Middle East and Africa (MEA)

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-13890

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusion and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Method Innovation / Development Trends

4. Key Inclusions

4.1. Porters Analysis

4.2. PESTLE Analysis

4.3. Product Adoption Analysis

4.4. Key Strategies of Key Manufacturers

4.5. Technology Assessment

4.6. Regulatory Scenario

Inquire Before Buying Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-13890

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs